Moderna
MRNA
#1129
Rank
A$28.85 B
Marketcap
A$72.75
Share price
-1.52%
Change (1 day)
67.80%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total assets

Total assets on the balance sheet as of December 2025 : A$17.94 Billion

According to Moderna 's latest financial reports the company's total assets are A$17.94 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Moderna - Total assets on balance sheet (from 2017 to 2025)

Total assets by year

Year Total assets Change
2025-12-31A$18.42 B-18.98%
2024-12-31A$22.73 B-15.93%
2023-12-31A$27.04 B-28.82%
2022-12-31A$37.99 B11.67%
2021-12-31A$34.02 B256.61%
2020-12-31A$9.54 B320.32%
2019-12-31A$2.27 B-18.49%
2018-12-31A$2.78 B100.51%
2017-12-31A$1.38 B-29.34%
2016-12-31A$1.96 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
A$289.67 B 1,514.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$161.33 B 799.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
A$199.02 B 1,009.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
A$0.10 B-99.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
A$10.8 M-99.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$7.22 B-59.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
A$2.33 B-87.00%๐Ÿ‡บ๐Ÿ‡ธ USA